Fiji is currently facing significant medicine shortages, impacting patients across the nation who are struggling to access essential treatments. The Pharmaceutical and Biomedical Services (FPBS), responsible for supplying over 200 health facilities, is encountering a mix of internal and external challenges that are contributing to these supply disruptions.
FPBS Director Jeremaia Mataika highlighted that some suppliers have been unable to meet quality standards as outlined in their contracts, leading to the return of substandard medicines. This situation is particularly concerning for patients with non-communicable diseases (NCD), as the demand for quality medicines often increases, creating what is referred to as a “shortage effect.”
The situation is further complicated by bureaucratic delays in the procurement process, particularly from the Solicitor-General’s Office, leading to significant gaps in medicine stocks. Health Minister Dr. Ratu Atonio Lalabalavu confirmed that contract terminations are in place for suppliers who do not comply with quality expectations, emphasizing the ministry’s commitment to finding alternative solutions to fill these gaps.
Experts in public health are advocating for a thorough reform of Fiji’s medicine procurement system, arguing that the current regulations hinder efficient and timely access to medicines. They emphasize that the need for safe and effective medicines transcends procedural regulations and highlights a critical public health issue.
While systemic changes to the procurement process are acknowledged as necessary, until those changes are implemented, vulnerable populations in Fiji will continue to face health risks due to inadequate access to critical medications.
In light of this challenging situation, it is important to recognize the efforts by health authorities to address these critical issues. The call for reform may bring about positive changes that will ultimately enhance healthcare access and quality for all Fijians. Continued advocacy from healthcare professionals and public health experts is crucial in pushing for the improvements needed to ensure that no one is left without necessary treatment in the future.
Leave a comment